Anti-astmatic drugs

• Prepared by-�Ms. Sucheta S. Pawar�Assistant professor �Department of Pharmacology

• Anti-Asthmatic Drugs:

Asthma is a chronic respiratory disease characterized by airway inflammation and bronchospasm, leading to recurring wheezing, breathlessness, chest tightness, and coughing. This presentation explores the diverse range of anti-asthmatic drugs, their mechanisms of action, and their role in managing asthma symptoms and improving quality of life.

​

• Understanding Asthma: Pathophysiology and Symptoms
• Pathophysiology

Asthma is characterized by airway inflammation and bronchospasm, caused by an interplay of factors including genetic predisposition, environmental triggers, and immune system dysfunction.

• Symptoms

Asthma symptoms include wheezing, shortness of breath, chest tightness, and coughing, often triggered by allergens, exercise, or respiratory infections.

​

Classification of Antiasthmatic Drugs

​

• Bronchodilators: Relaxing Airway Muscles

1. Beta2-Sympathomimetics

These drugs act by stimulating beta2-adrenergic receptors in the airway smooth muscle, leading to relaxation and bronchodilation.

2. Methylxanthines

They inhibit phosphodiesterase, increasing cAMP levels and promoting relaxation of airway smooth muscle.

3.Anticholinergics

These drugs block acetylcholine receptors, preventing bronchoconstriction induced by parasympathetic stimulation.

​

• Leukotriene Antagonists: Blocking Inflammatory Mediators

Leukotriene antagonists block the actions of leukotrienes, inflammatory mediators that contribute to airway inflammation, bronchoconstriction, and mucus production in asthma

​

• Mast Cell Stabilizers: Preventing Allergic Reactions

Mast cell stabilizers prevent the release of histamine and other inflammatory mediators from mast cells, reducing allergic reactions and inflammation in the airways.

​

• Corticosteroids: Reducing Inflammation

i. Systemic Corticosteroids

• These drugs are taken orally or intravenously, providing a systemic effect that reduces inflammation throughout the body.

ii. Inhalation Corticosteroids

• Delivered directly to the airways via inhalers, these drugs target inflammation specifically in the lungs, minimizing systemic side effects.

​

• Combination Therapies: Synergistic Approaches

Combination therapies, often involving bronchodilators and corticosteroids, provide a synergistic approach to managing asthma, addressing both bronchospasm and inflammation.

​

• Proper Inhaler Technique: Ensuring Effective Delivery

Proper inhaler technique is crucial for optimal drug delivery and effectiveness. Patients should receive thorough instruction on the correct steps, including coordinating inhalation with actuation, holding their breath, and rinsing their mouth after use.

​